Cancer

Items 251-260 of 387

per page
Set Descending Direction
  1. IL-6R (mouse):Fc (mouse) (rec.)
    CHI-MF-11006R
    CHI-MF-11006R-C05050 µg
    CHF 390.00
  2. IL-7 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
    AG-40B-0247
    AG-40B-0247-C05050 µg
    CHF 440.00
    IL-7 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
  3. IL-7 (human) (monomeric):Fc-KIH (human) (rec.)
    AG-40B-0238
    AG-40B-0238-C05050 µg
    CHF 440.00
    IL-7 (human) (monomeric):Fc-KIH (human) (rec.)
  4. IL-7 (mouse) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
    AG-40B-0256
    AG-40B-0256-C05050 µg
    CHF 440.00
    IL-7 (mouse) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
  5. ISG15 (human) (rec.) (Rhodamine 110)
    SBB-PS0002
    SBB-PS0002-C05050 µg
    CHF 434.00
    Signal to Background. The signal to background ratio was determined by 100% hydrolysis of either 50nM or 500nM ISG15-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH7.5, 100mM NaCl, 1mM TCEP, 0.1mg/ml BSA.
  6. Isthmin-1 (human) (rec.) (His)
    AG-40B-0214
    AG-40B-0214-C05050 µg
    CHF 360.00
    AG-40B-0214-30503 x 50 µg
    CHF 720.00
  7. Isthmin-1 (mouse) (rec.) (His)
    AG-40B-0215
    AG-40B-0215-C05050 µg
    CHF 330.00
    AG-40B-0215-30503 x 50 µg
    CHF 660.00
  8. Jagged-1 (human):Fc (human) (rec.)
    AG-40A-0081
    AG-40A-0081-C01010 µg
    CHF 235.00
    AG-40A-0081-C05050 µg
    CHF 430.00
    Induction of IL-6 expression in human dermal fibroblasts by Jagged-1 (human):Fc (human) (rec.) (Prod. No. AG-40A-0081). Method: Jagged-1 (human):Fc was coated on a 12-well plate at 1µg/ml overnight at 4°C. Human dermal fibroblasts were cultured in
  9. Jagged-1 (mouse):Fc (human) (rec.)
    AG-40A-0157T
    AG-40A-0157T-C01010 µg
    CHF 235.00
    AG-40A-0157T-C05050 µg
    CHF 480.00
  10. Jagged-2 (human):Fc (human) (rec.)
    AG-40A-0155Y
    AG-40A-0155Y-C01010 µg
    CHF 265.00

Items 251-260 of 387

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.